These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 38855160

  • 1. Transjugular intrahepatic portosystemic shunt for recompensating decompensated cirrhosis?
    Karagiannakis DS.
    World J Gastroenterol; 2024 May 28; 30(20):2621-2623. PubMed ID: 38855160
    [Abstract] [Full Text] [Related]

  • 2. Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria.
    Gao L, Li MB, Li JY, Liu Y, Ren C, Feng DP.
    World J Gastroenterol; 2023 Oct 14; 29(38):5383-5394. PubMed ID: 37900585
    [Abstract] [Full Text] [Related]

  • 3. Road to recompensation: Baveno VII criteria and transjugular intrahepatic portosystemic shunt in liver cirrhosis.
    Anis MA, Majeed AA, Abid S.
    World J Gastroenterol; 2024 Aug 28; 30(32):3743-3747. PubMed ID: 39221069
    [Abstract] [Full Text] [Related]

  • 4. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Aug 28; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F, Jepsen P, Amanavicius N, Aagaard NK.
    Scand J Gastroenterol; 2019 Jul 28; 54(7):899-904. PubMed ID: 31203699
    [Abstract] [Full Text] [Related]

  • 7. [Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing].
    Lyu Y, Han GH, Fan DM.
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun 20; 25(6):402-407. PubMed ID: 28763854
    [Abstract] [Full Text] [Related]

  • 8. Transjugular intrahepatic portosystemic shunt: A promising therapy for recompensation in cirrhotic patients.
    Jin YN, Zhang W.
    World J Gastroenterol; 2024 Apr 28; 30(16):2285-2286. PubMed ID: 38690019
    [Abstract] [Full Text] [Related]

  • 9. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S.
    World J Gastroenterol; 2014 Dec 07; 20(45):16996-7010. PubMed ID: 25493012
    [Abstract] [Full Text] [Related]

  • 10. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.
    Luo SH, Zhou MM, Cai MJ, Han SL, Zhang XQ, Chu JG.
    World J Gastroenterol; 2023 Apr 21; 29(15):2336-2348. PubMed ID: 37124886
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Parker R.
    Clin Liver Dis; 2014 May 21; 18(2):319-34. PubMed ID: 24679497
    [Abstract] [Full Text] [Related]

  • 14. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J, Fuentes-Valenzuela E, García-Pajares F, Nájera-Muñoz R, Almohalla-Álvarez C, Sánchez-Martín F, Calero-Aguilar H, Villacastín-Ruiz E, Pintado-Garrido R, Sánchez-Antolín G.
    Gastroenterol Hepatol; 2021 Nov 21; 44(9):620-627. PubMed ID: 33249114
    [Abstract] [Full Text] [Related]

  • 15. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.
    Horhat A, Bureau C, Thabut D, Rudler M.
    United European Gastroenterol J; 2021 Mar 21; 9(2):203-208. PubMed ID: 32819214
    [Abstract] [Full Text] [Related]

  • 16. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
    Wettstein M, Lüthen R, Cohnen M, von Wrisberg F, Mödder U, Häussinger D.
    Zentralbl Chir; 2005 Jun 21; 130(3):246-9. PubMed ID: 15965878
    [Abstract] [Full Text] [Related]

  • 17. The transjugular intrahepatic portosystemic shunt: an update.
    Fidelman N, Kwan SW, LaBerge JM, Gordon RL, Ring EJ, Kerlan RK.
    AJR Am J Roentgenol; 2012 Oct 21; 199(4):746-55. PubMed ID: 22997364
    [Abstract] [Full Text] [Related]

  • 18. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
    Strunk H, Marinova M.
    Rofo; 2018 Aug 21; 190(8):701-711. PubMed ID: 30045395
    [Abstract] [Full Text] [Related]

  • 19. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM, Li YH, Xu Y, Wu HM, Li YC, Wu XN, Yang JH.
    Acad Radiol; 2018 Jul 21; 25(7):925-934. PubMed ID: 29373208
    [Abstract] [Full Text] [Related]

  • 20. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M, He CY, Qi XS, Yin ZX, Wang JH, Guo WG, Niu J, Xia JL, Zhang ZL, Larson AC, Wu KC, Fan DM, Han GH.
    World J Gastroenterol; 2014 Jan 21; 20(3):774-85. PubMed ID: 24574750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.